Junior B. 7449dbeefb Scope Phase 2 structure-based binding track into PLAN (§12)
Add a scoped (not committed) follow-on track pivoting modality from
expression-connectivity to structure-based drug-target binding, motivated
by the empirical finding that the expression modality is signal-dead for
this task (relational-only supervised AUC = 0.49, chance).

§12 covers: the evidence for the pivot, a sickle-specific druggable target
shortlist with known-binder positive controls (Hb/voxelotor, PKR/mitapivat,
DNMT1/decitabine, LSD1, HDAC, EHMT2, PDE9), method (classical docking
baseline -> AF3-class co-folding: Boltz-2/Chai-1/DiffDock), a pre-registered
binding recovery test, integration with the expression layer as the real
prize, honest pitfalls (binding != efficacy, BCL11A untractable, GPU breaks
the all-local assumption), and open decisions before committing.

Co-Authored-By: Claude Opus 4.8 (1M context) <noreply@anthropic.com>
2026-06-23 23:40:18 +02:00

Reverso MVP — Sickle Cell Repurposing Pipeline

A minimum viable drug repurposing pipeline for sickle cell disease: build a disease signature from public transcriptomic data, build drug profiles for ~300 small molecules, and rank them by CMap-style connectivity scoring. Validated by a recovery test — do the two known sickle cell drugs (hydroxyurea, L-glutamine) rank near the top?

See PLAN.md for the full specification, locked decisions, and week-by-week build plan.

Quickstart

# Requires Python >=3.11,<3.13 (see note below)
pip install -e .            # or: pip install -e ".[dev]" for test/lint tooling
pytest                      # run unit tests

Python version note: use Python 3.113.13 (python3.13 -m venv .venv). Python 3.14 is not yet supported by all pipeline dependencies (pydeseq2, cmapPy).

Project layout

data/         raw (downloaded, never edited) / processed / results — gitignored
notebooks/    01..05, run end-to-end in order
src/          identifiers, disease, drugs, scoring, provenance
tests/        scoring unit tests
docs/         recovery_test_report.md, data_sources.md, known_limitations.md

The deliverable

When complete, the artifact to share is three files:

  1. docs/recovery_test_report.md — the 2-page write-up
  2. data/results/ranked_candidates_v1.csv — the ranked drug list
  3. The signature + drug profile files with provenance

Pipeline

Notebook Stage Output
01_setup_identifiers.ipynb Pin disease/gene IDs data/processed/identifiers.json
02_disease_signature.ipynb GEO + differential expression sickle_cell_signature_v1.json
03_drug_profiles.ipynb ChEMBL + LINCS drug_profiles_v1.parquet
04_connectivity_scoring.ipynb CMap scoring ranked_candidates_v1.csv
05_recovery_test.ipynb Validation docs/recovery_test_report.md

Every persisted artifact carries a confidence tier (A/B/C) and provenance. See PLAN.md §3.

Description
Drug Repurposing Tool
Readme 186 KiB
Languages
Python 93.8%
Jupyter Notebook 6.2%